Related Experiment Video
Updated: Jun 8, 2026

Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts
Published on: April 26, 2018
In vivo validation of free-space fluorescence tomography using nuclear imaging
Anikitos Garofalakis1, Albertine Dubois, Bertrand Kuhnast
1Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Institut d'Imagerie Biomédicale (I2BM), Service Hospitalier Frédéric Joliot (SHFJ), 4 place du Général Leclerc, 91401, Orsay Cedex, France.
Abstract:
The performance of small animal photonic imaging has been considerably improved since the development of fluorescence diffuse optical tomography (fDOT), which can reconstruct fluorescent probe distribution inside tissue. However, the quantification capabilities of this new technology are still a topic of debate, especially in comparison to classical nuclear imaging techniques. Here, we present a method to in vivo calibrate the quantity and localization of a probe provided by free-space fDOT (where no plate is compressing the mouse) with positron emission tomography (PET) and x-ray computed tomography, respectively. This methodology allowed us to demonstrate a strong linear correlation (R(2)=0.95) between fDOT and PET for probe concentrations ranging from 3 nM to 1 μM in a deep-seated organ.

